The Drug Policy Alliance 2009 International Conference
Albuquerque Convention Center — Albuquerque, New Mexico
Saturday, November 14, 2009, 3:00 PM – 4:30 PM
Room: Sleta / Jemez
Moderator: Howard Lotsof, President, Dora Weiner Foundation, Staten Island, NY
Mr. Lotsof is the recipient of this year’s Robert Randall Award for Achievement in the Field of Citizen Action
Ibogaine in opioid detoxification: How do we know it works? How does it work?
(The most often asked patient question)
Kenneth Alper, M.D., Associate Professor of Psychiatry and Neurology — New York University School of Medicine. USA
Safety Issues and Cardiac Side-Effects in the Administration of Ibogaine HCl, as an Addiction Interrupter Drug.
What we know, what we theorize and what we don’t know.
Jeffrey Kamlet, M.D., Fellow, American Society of Addiction Medicine, Miami, FL
Ibogaine User Self-Help Groups: Cross Cultural Development
Dimitri Mobengo Mugianis, Founding member, NYCAHN/VOCAL, NYC Drug Users Union. USA
An exploratory study of the short term effects of Ibogaine Treatment
Dr. Anwar Jeewa, DoBDS, HRST, MSocSc
The Benefits & Risks of Treating with Ibogaine in a Clinical Setting: 3 Case Studies
Clare Wilkins, Ibogaine Association, Playas, de Tijuana, Mexico
Bwiti and iboga, Working properly and safely with iboga or ibogaine and Ibogaine antidotes
Patrick Moughenda Mickala, Nganga, Massango and Mitsogho tribe, Gabon